1. Home
  2. BTMD vs KYNB Comparison

BTMD vs KYNB Comparison

Compare BTMD & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.07

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

HOLD

Current Price

$4.67

Market Cap

32.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
KYNB
Founded
2012
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
32.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BTMD
KYNB
Price
$1.07
$4.67
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$2.61
★ $38.50
AVG Volume (30 Days)
★ 108.3K
21.1K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
722.22
★ 9552.08
EPS
★ N/A
N/A
Revenue
★ $192,219,000.00
$6,440,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.45
$14.12
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.00
$4.85
52 Week High
$3.01
$9.66

Technical Indicators

Market Signals
Indicator
BTMD
KYNB
Relative Strength Index (RSI) 38.64 24.00
Support Level $1.00 N/A
Resistance Level $1.68 $7.41
Average True Range (ATR) 0.10 0.35
MACD 0.01 -0.07
Stochastic Oscillator 32.00 2.23

Price Performance

Historical Comparison
BTMD
KYNB

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: